Inclisiran Approval Held Up by Inspection-Related Issues
Inclisiran is a chemically synthesized small interfering RNA that targets proprotein convertase subtilisin-kexin type 9 (PCSK9) messenger RNA.
Cardiovascular Disease
Hypertension: Beta-Blocker Pharmacokinetics
Beta-blocker pharmacokinetics comparison chart for hypertension.
Hypertension Treatments: ACE Inhibitors
A comparative list of Angiotensin-Converting Enzyme (ACE) Inhibitors monotherapy and combination therapy for the treatment of hypertension.
Combination Hypertension Treatments
A comparative list of combination antihypertensive medications.
Hypertension Treatments: ARBs
A comparative list of Angiotensin II Receptor Blockers (ARBs) monotherapy and combination therapy for the treatment of hypertension.
Hypertension Treatments: Oral CCBs
Oral calcium channel blockers (CCBs) for the treatment of hypertension including benzothiazepines, dihydropyridines, and diphenylalkylamines.
Hypertension Treatment Algorithm
Management of hypertension in adults based on evidence-based guidelines.
Hypertension Treatments: Diuretics
A comparative list of loop, potassium-sparing, and thiazide-like diuretics monotherapy and combination therapy for the treatment of hypertension.
Hypertension Evaluation
Blood pressure classification, diagnostic workup of hypertension, assess for major cardiovascular disease risk factors and identifiable causes, and blood pressure measurement techniques.
Dyslipidemia Drug Indications
Comparative chart of single and combination treatment options indicating which lipids can be targeted for dyslipidemias.
-
Loading...
-
Loading...
Next post in Uncategorized
